L. Smith
Net worth: 8 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Saqib Islam | M | 54 | 7 years | |
| Alan Fuhrman | M | 67 | 5 years | |
| Herschel Weinstein | M | 68 | 4 years | |
| Freda Lewis-Hall | M | 69 | 7 years | |
| Carlos Alban | M | 61 | 2 years | |
| Judy Olian | M | 72 | 9 years | |
| Julie Hambleton | M | 66 | 4 years | |
| Badreddin Edris | M | 37 | 6 years | |
| Kim Diamond | F | - | 6 years | |
| Frank Perier | M | 64 | 5 years | |
| Michael Nofi | M | 53 | 5 years | |
| Daniel Pichl | M | 41 | 4 years | |
| Bhavesh Ashar | M | 58 | 3 years | |
| James Cassidy | M | 65 | 3 years | |
| Tai-An Lin | M | 61 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Maxim Ferrari | M | 69 | 14 years | |
| Sheila Mikhail | F | 57 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 years |
| Deval Patrick | M | 67 | 2 years | |
| Stephen P. Squinto | M | 67 | 5 years | |
| Carl Gordon | M | 59 | 2 years | |
| Michael V. Greco | M | 53 | 1 years | |
| Jeffrey Schwartz | M | 45 | 6 years | |
| Josh Grieger | M | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 3 years |
| Michael Burgess | M | 61 | 1 years | |
| Rhonda L. Stanley | F | 64 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 years |
| Renu Vaish | F | - | - | |
| Alexander Sapir | M | 57 | 10 years | |
| Jens Renstrup | M | 59 | 3 years | |
| Scott Moomaw | M | 54 | 5 years | |
| Paul Herzich | M | 46 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 30 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- L. Smith
- Personal Network
